Expect litigation by Bayer for its anti cancer drug: Natco Pharma
P Bhaskara Narayana, director and CFO at Natco, Ahmedabad says the firm expects litigation by Bayer for permission by the Centre for selling copycat version of the anti-cancer drug.
